• Sanofi (France) (SAN.PA) Confirms Plan to Leave Toulouse R&D Site More...

• GlaxoSmithKline (GSK) is Interested in BioMarin Pharmaceutical Inc. (BMRN)...Again? More...

• Apricus Biosciences (APRI) Announces Closing of Finesco-Scomedica Transaction More...

• De Facto in MBO From Chime plc. More...

• Genmab A/S (GEN.CO) Strikes Antibody R&D Pact Worth $178.5 Million With Johnson & Johnson (JNJ)'s Janssen Biotech Inc. More...

• Pressure BioSciences, Inc. (BBII) Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand More...

• Fero Industries, Inc. Announces Corporate Restructuring More...

• RXi Pharmaceuticals (RXII) Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board More...

• Dendreon Corporation (DNDN) to Host Conference Call on July 30 to Announce Second Quarter Financial Results and Webcast Presentation at Upcoming Conference More...

• Elan Corporation PLC (ELN) Announces Webcast of Second Quarter 2012 Financial Results More...

• Illumina, Inc. (ILMN) to Announce Second Quarter 2012 Results on Tuesday, July 24, 2012 More...

• MEDICREA: H1 2012 Sales More...

• Thermo Fisher Scientific (TMO) Declares Quarterly Dividend More...

• Purdue Pharma L.P.'s Redesigned OxyContin Drives Heroin Use More...

• Health Canada: GlaxoSmithKline (GSK) Issues Warning on Pulmonary Arterial Hypertension Drug More...

• Watson Pharmaceuticals, Inc. (WPI)s Generic Version of Plan B One-Step&#0174 Receives FDA Approval More...

• GlaxoSmithKline (GSK) Pulls US Bid to Use Tykerb With Roche (RHHBY)'s Herceptin More...

• Supernus Pharmaceuticals (SUPN) Provides Update on the Launch of Its Two Epilepsy Products Trokendi XR™ and SPN-804 More...

• Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval More...

• GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Regulatory Submissions for FF/VI in the US and Europe More...

• Celgene (CELG) Psoriatic Arthritis Drug Effective in Phase 3 Trial More...

• Immune Response BioPharma Review of Blockbuster RAVAX Phase 2B Study Patients 50% Improvement More...

• MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Launches Critical Limb Ischemia Clinical Trial More...

• Women Dance Most Attractively When Fertile, University of Gottingen Study More...

• Saliva and Pupil Size Differences in Autism Show System in Overdrive,University of Kansas Study More...

• Obese Kids as Bright as Thinner Peers, University of York Study More...

• HPV Vaccine Proves Effective! Cincinnati Children's Hospital Medical Center Study More...

• Alnylam Pharmaceuticals (ALNY) and Collaborators Publish Scientific Paper Documenting Discovery of Second Generation MC3 Lipid Nanoparticles (LNPs) More...